WuXi Biologics (Cayman) Inc.
2269
Classement en actions
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Prix de l'action
$5.73
Capitalisation boursière
$23.57B
Changement (1 jour)
-9.03%
Changement (1 an)
24.25%
Pays
CN
Échange WuXi Biologics (Cayman) Inc. (2269)
Catégorie
Healthcare
Ratio P/B pour WuXi Biologics (Cayman) Inc. (2269)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de WuXi Biologics (Cayman) Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour WuXi Biologics (Cayman) Inc. de 2014 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2025 | 2.49 | 54.96% |
| 2024 | 1.61 | -40.03% |
| 2023 | 2.68 | -57.33% |
| 2022 | 6.29 | -38.77% |
| 2021 | 10.28 | -41.50% |
| 2020 | 17.56 | 91.24% |
| 2019 | 9.18 | 26.97% |
| 2018 | 7.23 | -26.16% |
| 2017 | 9.80 | -90.76% |
| 2016 | 106.02 | -42.27% |
| 2015 | 183.65 | 166.79% |
| 2014 | 68.84 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| 6.1824 | - |
NL
|
|
| - | - |
CH
|
